Tandlægerne i Børkop ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.1% 1.0% 1.0% 0.9% 0.8%  
Credit score (0-100)  85 86 86 90 89  
Credit rating  A A A A A  
Credit limit (kDKK)  166.5 349.1 399.7 462.9 473.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  2,821 3,193 2,951 3,053 2,759  
EBITDA  1,500 1,985 1,789 1,816 1,451  
EBIT  1,099 1,580 1,398 1,586 1,239  
Pre-tax profit (PTP)  1,015.5 1,568.5 1,361.8 1,532.9 1,187.8  
Net earnings  794.7 1,221.9 1,027.4 1,180.3 922.7  
Pre-tax profit without non-rec. items  1,016 1,569 1,362 1,533 1,188  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,182 3,028 2,647 5,333 5,293  
Shareholders equity total  3,659 4,381 4,408 4,588 4,511  
Interest-bearing liabilities  238 512 836 1,237 1,659  
Balance sheet total (assets)  4,752 6,007 5,916 6,405 6,689  

Net Debt  -398 -1,688 -1,640 822 778  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,821 3,193 2,951 3,053 2,759  
Gross profit growth  29.4% 13.2% -7.6% 3.5% -9.6%  
Employees  6 6 6 5 5  
Employee growth %  0.0% 0.0% 0.0% -16.7% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,752 6,007 5,916 6,405 6,689  
Balance sheet change%  -1.3% 26.4% -1.5% 8.3% 4.4%  
Added value  1,500.3 1,985.4 1,788.9 1,977.3 1,450.7  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -777 -681 -893 2,335 -373  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  39.0% 49.5% 47.4% 51.9% 44.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  23.0% 29.4% 23.4% 25.7% 18.9%  
ROI %  25.7% 34.2% 26.7% 28.0% 20.3%  
ROE %  24.4% 30.4% 23.4% 26.2% 20.3%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  77.0% 72.9% 74.5% 71.6% 67.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -26.5% -85.0% -91.7% 45.3% 53.6%  
Gearing %  6.5% 11.7% 19.0% 27.0% 36.8%  
Net interest  0 0 0 0 0  
Financing costs %  11.6% 3.0% 5.3% 5.1% 3.6%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.9 1.6 2.0 0.3 0.5  
Current Ratio  0.9 1.6 2.0 0.3 0.5  
Cash and cash equivalent  635.3 2,200.1 2,475.8 415.0 881.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -120.0 811.6 1,299.3 -1,104.2 -1,040.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  250 331 298 395 290  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  250 331 298 363 290  
EBIT / employee  183 263 233 317 248  
Net earnings / employee  132 204 171 236 185